56. Behcet disease Clinical trials / Disease details
Clinical trials : 81 / Drugs : 107 - (DrugBank : 30) / Drug target genes : 36 - Drug target pathways : 116
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR2100044593 | 2021-03-15 | 2021-03-24 | Clinical study of endoscopic treatment for Patients with intestinal Behcet's disease having poor response to conventional treatment | Clinical study of endoscopic treatment for Patients with intestinal Behcet's disease having poor response to conventional treatment | intestinal Behcet's disease | Single group:Endoscopic injection of triamcinolone acetonide; | The First Affiliated Hospital of Sun Yat-Sen University | ,NULL | Recruiting | 16 | 70 | Both | Single group:30; | China | |
| 2 | NCT03771768 (ClinicalTrials.gov) | May 25, 2019 | 1/12/2018 | Diode Laser Versus Topical Corticosteroids in Management of Oral Ulcers in Behcet's Disease | Active Control,Randomized,Double- Blinded Clinical Trial of BD | Autoimmune;Behcet Syndrome | Radiation: Diode laser 980nm&100 mWatt;Drug: Triamcinolone Acetonide | Cairo University | NULL | Not yet recruiting | 18 Years | 60 Years | All | 38 | N/A | NULL |